There are so many biotech companies in Maryland, a major life sciences hub in the United States. Maryland is home to top life sciences companies and institutions such as the FDA, National Institutes of Health (NIH), AstraZeneca, Lonza, BD, GSK, Qiagen, Ambu, Immunocore, United Therapeutics Corporation, and Sonavi Labs.
Maryland is the heart of neuroscience research in the US, with institutions such as the Johns Hopkins University, Baltimore, the Lieber Institute for Brain Development, and the Institute for Neuroscience Discovery (UM-MIND) in the University of Maryland School of Medicine, pioneering research in the sector.
Johns Hopkins is the birthplace of modern neurosurgery and has institutes such as the Kavli Neuroscience Discovery Institute, Pedersen Brain Science Institute and Solomon H. Snyder Department of Neuroscience.
Also, the National Institutes of Health (NIH) and its National Institute of Neurological Disorders and Stroke, also conduct research in neurology. In the US, Maryland is the second-most educated state.
Some incentives and funding helps to fuel research and innovation in the biotech sector in Maryland. They include the Biotechnology Investment Incentive Tax Credit (BIITC), Research and Development Tax Credit (R&D), and the Maryland Innovation Investment Tax Credit (IITC).
Top biotech hubs in Maryland include Rockville, Gaithersburg, Baltimore, Frederick (Jefferson Technology Park, Riverside Research Park), Germantown (Milestone Innovation Park).
